"meUusSoulAI" The Starting Point _ A Guided Reflection Pilot

The company appears to be a solo project named "meUusSoulAI" — a guided reflection pilot built as a limited, consent-based AI interaction for adults. The author describes it as an experimental, non-diagnostic, non-clinical tool that helps users pause, express what matters, and identify one possible next step through a structured conversation with an AI. It is not presented as therapy or a replacement for human care.

The description states that meUusSoulAI is a guided reflection pilot designed to help adults pause and reflect on what currently affects them. It involves:

• An 18+ age gate;
• Explicit consent before beginning;
• A maximum of five guided messages;
• Restrained, non-diagnostic language;
• Structured storage of only approved mapped fields;
• One possible next-step suggestion;
• Closure with a concise reflection.

The system uses n8n for workflow orchestration, an OpenAI model (gpt-5-mini) for responses, and Google Sheets to append structured data. It is built as a small vertical slice, not a full application or service.

This is described as a local release-candidate workflow, not yet publicly deployed.

The author states that the project is:

• A limited reflection pilot;
• Not therapy, diagnosis, counselling, medical advice, legal advice, emergency assistance, or crisis monitoring;
• An early preview of a possible future meYoo Reflection Mode within the wider meUus ecosystem;
• Intended to explore whether AI can support honest reflection while remaining clear about its limitations.

It is positioned as:

• A small moment of reflection, not a large system;
• Not meant to replace people or provide care, but to explore AI’s role in supporting reflection;
• Part of a broader vision: “me → U → us” — individual to shared responsibility.

There are no claims about commercial traction, revenue, or adoption. The positioning is experimental and exploratory.

The description states that the pilot targets:

• Adults (18+);
• People who may benefit from a calm, structured moment to understand what they are carrying;
• Individuals who struggle with:
  • Explaining what they’re feeling;
  • Identifying real issues beneath connected problems;
  • Slowing down before reacting;
  • Distinguishing emotion from practical next steps;
  • Asking for appropriate human help;
  • Moving from reflection into action.

The ICP is not defined beyond "adults" and the target audience is not further segmented or quantified.

Not evidenced. The description does not state anything about pricing, monetization, or a business model. It is described as an experimental pilot, not a commercial offering.

The project uses:

• n8n for workflow orchestration;
• OpenAI gpt-5-mini for responses;
• Google Sheets to append structured data;
• Explicit field mapping to prevent unintended data collection;
• Controlled record append with safety and scope limitations;
• Local testing and evidence capture before public release.

It is described as a small vertical slice, not a full application. The system is built in stages, with emphasis on:

• Scope reduction;
• Conversation boundaries;
• Structured workflow;
• Evidence-based testing;
• Hardening of the workflow.

The pilot is not publicly deployed, only locally verified.

Not evidenced. There is no mention of users, customers, revenue, or adoption. The project is described as a local release candidate and an experimental pilot — not yet in production or validated with real users.

Not evidenced. No mention of competitors, market size, or competitive positioning is provided in the description.

• No commercial traction or evidence of adoption;
• No revenue, customers, or monetization strategy;
• Only a local release candidate, not publicly deployed;
• Highly limited scope and functionality — not a full product or service;
• Self-reported only, with no independent verification;
• Risk of overclaiming: The author explicitly warns against describing the pilot as more than it is, but the project’s positioning may still be interpreted as a commercial offering if not carefully communicated.

1. What is the intended path from this pilot to a full meUus service?
2. Is there any plan for clinical validation or human review integration?
3. How does the team intend to scale beyond the current local workflow?
4. What are the privacy and data governance implications of expanding the field mapping or data collection?
5. Are there any plans for monetization, user onboarding, or commercial partnerships?
6. Has the pilot been tested with real users, or is it purely internal?
7. How does the team plan to ensure safety and responsible use at scale?